Effects of wortmannin on airways inflammation induced by allergen in actively sensitised Brown Norway rats
Introduction
Mast cells play a major role in allergy and inflammation Wasserman, 1983, Galli, 1997, Metcalfe et al., 1997, Bakharevski and Ryan, 1999, Holt et al., 1999. Pivotal to the effector function of mast cells is their activation through the interaction of a multivalent antigen (allergen) with its specific immunoglobulin E (IgE) antibody bound to its high affinity receptor, FcεRI. Signalling through FcεRI is initiated by cross-linking of allergen bound to IgE which leads to mast cell degranulation and the release of mediators such as histamine, 5-hydroxytryptamine and proteases, the production of leukotrienes and prostaglandins and the release and synthesis of chemokines and cytokines Church et al., 1997, Metcalfe et al., 1997. The evidence is compelling that mast cells coordinate and facilitate the development of allergic inflammation Wasserman, 1983, Galli, 1997, Metcalfe et al., 1997.
Phosphatidylinositol-3-kinase is associated with, and activated by, a number of protein tyrosine kinases and plays an important role in signalling pathways initiated by several growth factor receptors Vlahos, 1995, Shepherd et al., 1996, Cardenas et al., 1998. Phosphatidylinositol-3-kinase is also activated in mast cells following cross-linking of multivalent allergen bound to IgE and is involved in the signal transduction pathway responsible for degranulation and the release of bioactive mediators Yano et al., 1993, Marquardt et al., 1996, Pendl et al., 1997, Bhattacharyya et al., 1998. Phosphatidylinositol-3-kinase is also involved in chemotaxis and the oxidative burst in leukocytes in response to a variety of stimuli Arcaro and Wymann, 1993, Niggli and Keller, 1997, Lennartz, 1999, Rameh and Cantley, 1999, Miike et al., 2000.
An essential factor implicating phosphatidylinositol-3-kinase in an obligatory role in inflammatory cell function is that the responses can be abolished by low concentrations of wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase Ui et al., 1995, Cardenas et al., 1998. We report here the effect of wortmannin on the immediate-type allergic response and the late phase pulmonary inflammation induced by allergen challenge in an animal model of allergic asthma, the ovalbumin-sensitised Brown Norway rat.
A part of the results was presented at the meeting of the British Pharmacological Society held in July 1999 (Tigani et al., 1999).
Section snippets
Animals
Male Brown Norway rats weighing 200–300 g were supplied by Biological Research Laboratories (Füllinsdorf, Switzerland). They were kept at an ambient temperature of 22±2 °C under a 12-h normal phase light–dark cycle and fed on NAFAG pellets supplied by Nahr und Futtermittel, Gossau, Switzerland. Drinking water was freely available. All experiments were carried out with the approval of the Veterinary Authority of the City of Basel (Kantonales Veterinaeramt, Basel-Stadt).
Sensitisation procedure
Ovalbumin (20 μg ml−1) was
Acute bronchoconstrictor responses to intratracheal administration of ovalbumin in actively sensitised Brown Norway rats: effect of pretreatment with wortmannin
Intratracheal (i.t.) instillation of ovalbumin (3–60 mg kg−1) induced dose-related bronchoconstrictor responses, which peaked at 5 min and resolved within 15 min (Fig. 1). Pretreatment with wortmannin (1, 10 or 100 μg kg−1 i.t., 1 h prior to challenge) induced a dose-dependent inhibition of the bronchospasm induced by ovalbumin (60 mg kg−1). The ED50 was approximately 5 μg kg−1 (Fig. 2). By interpolation from the ovalbumin dose–response relationship, the degree of blockade by wortmannin (10 μg
Discussion
Our results demonstrate potent inhibition by wortmannin of the acute early bronchoconstrictor response to ovalbumin in actively sensitised Brown Norway rats. At similar doses, wortmannin also inhibited the bronchoconstrictor responses to 5-hydroxytryptamine and methacholine. However, the degree of inhibition of these spasmogens (1.4–1.9-fold following the 10 μg kg−1 dose of wortmannin) was markedly less than that of ovalbumin (>20-fold). Thus, nonselective suppression of bronchial contractility
References (31)
- et al.
Signal transduction cascades as targets for therapeutic intervention by natural products
Trends Biotechnol.
(1998) - et al.
Effect of nedocromil sodium on allergen-induced airway responses and changes in the quantity of airway smooth muscle in rats
J. Allergy Clin. Immunol.
(1996) - et al.
Antigen induced recruitment of eosinophils: importance of CD4+ T cells, IL-5 and mast cells
Clin. Immunol. Immunopathol.
(1994) Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis
Int. J. Biochem. Cell Biol.
(1999)- et al.
The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils
Eur. J. Pharmacol.
(1997) - et al.
The role of phosphoinositide3-kinase lipid products in cell function
J. Biol. Chem.
(1999) - et al.
Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase
Trends Biotechnol.
(1995) Mediators of immediate hypersensitivity
J. Allergy Clin. Immunol.
(1983)- et al.
Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells
J. Biol. Chem.
(1993) - et al.
Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses
Biochem. J.
(1993)
Mast cells as a target in the treatment of rheumatoid arthritis
Inflammopharmacology
Pulmonary oedema induced by allergen challenge in the rat: non-invasive assessment by magnetic resonance imaging
Magn. Reson. Med.
Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact
J. Leukocyte Biol.
Human mast cells and basophils
Nedocromil sodium and sodium cromoglycate: pharmacology and putative modes of action
Cited by (27)
KGC3P attenuates ovalbumin-induced airway inflammation through downregulation of p-PTEN in asthmatic mice
2019, PhytomedicineCitation Excerpt :The PI3K pathway attracts inflammatory mediators and activates eosinophils (Kwak et al., 2003). In asthma, PI3K inhibitors reduce eosinophilic inflammation and airway hyperresponsiveness (Tigani et al., 2001). Therefore, pharmacological targeting of PPARγ and PTEN may be a new strategy for the treatment of allergic asthma.
Biphasic airway-lung response to anaphylactic shock in Brown Norway rats
2013, Respiratory Physiology and NeurobiologyCitation Excerpt :This was observed at the level of trachea (from 9.4 ± 4.9 ng mg−1 to 133.7 ± 7.9 ng mg−1) and bronchi (from 11.5 ± 8.1 ng mg−1 to 116.5 ± 8.9 ng mg−1) as well as smaller airways (from 8.5 ± 5.6 ng mg−1 to 108.4 ± 5.5 ng mg−1). While the ovalbumin-sensitized Brown Norway rat has been used to characterize the airway (Ellis et al., 2003, 2004; Hele et al., 2001; Tigani et al., 2001, 2003; Werner-Klein et al., 2008; Wollin et al., 2006) – or the cardiovascular effects of ovalbumin challenge (Dewachter et al., 2005; Zheng et al., 2013), we are aware of little data that describe the full respiratory mechanics response during anaphylactic shock in that model. The lung response to intravenous OVA has previously been assessed mostly from the change in lung resistance averaged over a period of time (Ellis et al., 2003).
The PH domain adaptor protein Bam32/DAPP1 functions in mast cells to restrain Fce{open}RI-induced calcium flux and granule release
2010, Molecular ImmunologyCitation Excerpt :The phosphatidylinositol 3-kinase (PI3K) pathway has been shown to be particularly critical in FcɛRI signaling (Barker et al., 1995, 1998; Hirasawa et al., 1997; Marquardt et al., 1996; Tigani et al., 2000; Yano et al., 1993). Blockade of PI3K activity in vivo has been shown to attenuate allergic airway inflammation in animal models (Kwak et al., 2003; Tigani et al., 2001), consistent with the importance of this pathway in atopic disease. The p110δ isoform was shown to contribute the majority of PI3K activity in mast cells and be critical for FcɛRI signaling and mast cell function (Ali et al., 2004).
Taming the PI3K team to hold inflammation and cancer at bay
2008, Pharmacology and TherapeuticsPhosphoinositide 3-kinase (PI3K) family of signalling enzymes and their role in asthma
2006, Drug Discovery Today: Disease MechanismsDoxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma
2004, Journal of Allergy and Clinical Immunology